S&P 500   0.67 (+1.82%)
DOW   0.67 (+1.82%)
QQQ   265.19 (-1.89%)
AAPL   452.04 (+3.32%)
MSFT   209.19 (+2.86%)
FB   259.89 (+1.47%)
GOOGL   1,507.24 (+1.80%)
AMZN   3,162.24 (+2.65%)
NVDA   457.61 (+5.44%)
CGC   17.25 (+1.77%)
BABA   255.19 (+2.73%)
TSLA   1,554.76 (+13.12%)
GE   6.72 (-0.15%)
MU   48.48 (+1.51%)
AMD   82.61 (+7.45%)
T   30.18 (-0.07%)
F   7.11 (-1.66%)
ACB   9.80 (-2.20%)
GILD   68.84 (+1.09%)
NFLX   475.47 (+1.83%)
DIS   131.79 (+1.00%)
BAC   26.73 (-0.71%)
BA   175.44 (-2.60%)
S&P 500   0.67 (+1.82%)
DOW   0.67 (+1.82%)
QQQ   265.19 (-1.89%)
AAPL   452.04 (+3.32%)
MSFT   209.19 (+2.86%)
FB   259.89 (+1.47%)
GOOGL   1,507.24 (+1.80%)
AMZN   3,162.24 (+2.65%)
NVDA   457.61 (+5.44%)
CGC   17.25 (+1.77%)
BABA   255.19 (+2.73%)
TSLA   1,554.76 (+13.12%)
GE   6.72 (-0.15%)
MU   48.48 (+1.51%)
AMD   82.61 (+7.45%)
T   30.18 (-0.07%)
F   7.11 (-1.66%)
ACB   9.80 (-2.20%)
GILD   68.84 (+1.09%)
NFLX   475.47 (+1.83%)
DIS   131.79 (+1.00%)
BAC   26.73 (-0.71%)
BA   175.44 (-2.60%)
S&P 500   0.67 (+1.82%)
DOW   0.67 (+1.82%)
QQQ   265.19 (-1.89%)
AAPL   452.04 (+3.32%)
MSFT   209.19 (+2.86%)
FB   259.89 (+1.47%)
GOOGL   1,507.24 (+1.80%)
AMZN   3,162.24 (+2.65%)
NVDA   457.61 (+5.44%)
CGC   17.25 (+1.77%)
BABA   255.19 (+2.73%)
TSLA   1,554.76 (+13.12%)
GE   6.72 (-0.15%)
MU   48.48 (+1.51%)
AMD   82.61 (+7.45%)
T   30.18 (-0.07%)
F   7.11 (-1.66%)
ACB   9.80 (-2.20%)
GILD   68.84 (+1.09%)
NFLX   475.47 (+1.83%)
DIS   131.79 (+1.00%)
BAC   26.73 (-0.71%)
BA   175.44 (-2.60%)
S&P 500   0.67 (+1.82%)
DOW   0.67 (+1.82%)
QQQ   265.19 (-1.89%)
AAPL   452.04 (+3.32%)
MSFT   209.19 (+2.86%)
FB   259.89 (+1.47%)
GOOGL   1,507.24 (+1.80%)
AMZN   3,162.24 (+2.65%)
NVDA   457.61 (+5.44%)
CGC   17.25 (+1.77%)
BABA   255.19 (+2.73%)
TSLA   1,554.76 (+13.12%)
GE   6.72 (-0.15%)
MU   48.48 (+1.51%)
AMD   82.61 (+7.45%)
T   30.18 (-0.07%)
F   7.11 (-1.66%)
ACB   9.80 (-2.20%)
GILD   68.84 (+1.09%)
NFLX   475.47 (+1.83%)
DIS   131.79 (+1.00%)
BAC   26.73 (-0.71%)
BA   175.44 (-2.60%)
Log in

NASDAQ:OGIOrganiGram Stock Price, Forecast & News

$1.33
-0.01 (-0.75 %)
(As of 08/12/2020 04:00 PM ET)
Add
Compare
Today's Range
$1.32
Now: $1.33
$1.40
50-Day Range
$1.23
MA: $1.47
$1.88
52-Week Range
$1.09
Now: $1.33
$5.60
Volume2.99 million shs
Average Volume4.82 million shs
Market Capitalization$233.68 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.11
OrganiGram Holdings Inc., through its subsidiaries, produces and sells dried cannabis and cannabis oil in Canada. It also offers wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis oils to retailers and wholesalers. The company also exports its products. It sells its products online, as well as through phone orders. OrganiGram Holdings Inc. was founded in 2013 and is headquartered in Moncton, Canada.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 4.2Community Rank: 3.1Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.71 out of 5 stars


Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:OGI
CUSIPN/A
CIKN/A
Phone1-855-961-9420

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$61.27 million
Cash Flow$0.11 per share
Book Value$1.58 per share

Profitability

Net Income$-7,200,000.00
Net Margins-142.02%

Miscellaneous

Employees615
Market Cap$233.68 million
Next Earnings Date11/24/2020 (Estimated)
OptionableNot Optionable
$1.33
-0.01 (-0.75 %)
(As of 08/12/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive OGI News and Ratings via Email

Sign-up to receive the latest news and ratings for OGI and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











OrganiGram (NASDAQ:OGI) Frequently Asked Questions

How has OrganiGram's stock been impacted by Coronavirus (COVID-19)?

OrganiGram's stock was trading at $1.72 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, OGI stock has decreased by 22.7% and is now trading at $1.33.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of OrganiGram?

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for OrganiGram in the last year. There are currently 9 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for OrganiGram
.

When is OrganiGram's next earnings date?

OrganiGram is scheduled to release its next quarterly earnings announcement on Tuesday, November 24th 2020.
View our earnings forecast for OrganiGram
.

How were OrganiGram's earnings last quarter?

OrganiGram Holdings Inc (NASDAQ:OGI) posted its quarterly earnings results on Tuesday, July, 21st. The company reported ($0.51) EPS for the quarter, missing analysts' consensus estimates of ($0.02) by $0.49. The firm had revenue of $22.24 million for the quarter, compared to the consensus estimate of $20.83 million. OrganiGram had a negative return on equity of 4.88% and a negative net margin of 142.02%. The firm's quarterly revenue was down 26.7% on a year-over-year basis. During the same quarter in the prior year, the business earned ($0.07) EPS.
View OrganiGram's earnings history
.

What price target have analysts set for OGI?

15 equities research analysts have issued 1 year price targets for OrganiGram's shares. Their forecasts range from $1.72 to $8.50. On average, they anticipate OrganiGram's share price to reach $3.80 in the next year. This suggests a possible upside of 185.3% from the stock's current price.
View analysts' price targets for OrganiGram
.

Has OrganiGram been receiving favorable news coverage?

Media stories about OGI stock have trended somewhat negative recently, according to InfoTrie Sentiment. The research firm identifies negative and positive press coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. OrganiGram earned a daily sentiment score of -1.2 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the near future.
View the latest news about OrganiGram
.

Are investors shorting OrganiGram?

OrganiGram saw a increase in short interest in the month of February. As of February 28th, there was short interest totaling 11,990,000 shares, an increase of 19.3% from the February 13th total of 10,050,000 shares. Based on an average trading volume of 3,970,000 shares, the days-to-cover ratio is presently 3.0 days.
View OrganiGram's Short Interest
.

Who are some of OrganiGram's key competitors?

What other stocks do shareholders of OrganiGram own?

Who are OrganiGram's key executives?

OrganiGram's management team includes the following people:
  • Mr. Greg Engel, CEO & Director (Age 54)
  • Mr. Paolo De Luca C.A., C.F.A, Chief Financial Officer (Age 46)
  • Mr. Jeff Purcell, VP - Operations
  • Mr. Timothy Emberg, Sr. VP of Sales & Commercial Operations
  • Mr. Peter R. Hanson, Director of Fin.

What is OrganiGram's stock symbol?

OrganiGram trades on the NASDAQ under the ticker symbol "OGI."

Who are OrganiGram's major shareholders?

OrganiGram's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include AdvisorShares Investments LLC (0.70%), Swiss National Bank (0.21%), Goldman Sachs Group Inc. (0.06%), Commonwealth Equity Services LLC (0.05%), Bank of Montreal Can (0.03%) and XTX Markets LLC (0.02%).

Which institutional investors are selling OrganiGram stock?

OGI stock was sold by a variety of institutional investors in the last quarter, including Commonwealth Equity Services LLC, and Bank of Montreal Can.

Which institutional investors are buying OrganiGram stock?

OGI stock was purchased by a variety of institutional investors in the last quarter, including AdvisorShares Investments LLC, Swiss National Bank, Goldman Sachs Group Inc., and XTX Markets LLC.

How do I buy shares of OrganiGram?

Shares of OGI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is OrganiGram's stock price today?

One share of OGI stock can currently be purchased for approximately $1.33.

How big of a company is OrganiGram?

OrganiGram has a market capitalization of $233.68 million and generates $61.27 million in revenue each year. The company earns $-7,200,000.00 in net income (profit) each year or $0.06 on an earnings per share basis. OrganiGram employs 615 workers across the globe.

What is OrganiGram's official website?

The official website for OrganiGram is www.organigram.ca.

How can I contact OrganiGram?

OrganiGram's mailing address is 35 English Dr., Moncton Z4, E1E 3X3. The company can be reached via phone at 1-855-961-9420.

This page was last updated on 8/12/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.